Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity
Condition(s):Hepatitis; TuberculosisLast Updated:April 22, 2009Completed
Hide Studies Not Open or Pending
Condition(s):Hepatitis; TuberculosisLast Updated:April 22, 2009Completed
Condition(s):Acute-On-Chronic Liver FailureLast Updated:January 23, 2020Completed
Condition(s):ObesityLast Updated:June 2, 2017Completed
Condition(s):Leiomyoma, Uterine; Liver Injury; Treatment Side EffectsLast Updated:July 9, 2019Unknown status
Condition(s):Alcoholic Hepatitis; Alcoholic CirrhosisLast Updated:December 11, 2012Completed
Condition(s):Non-alcoholic Fatty Liver Disease (NAFLD)Last Updated:March 30, 2017Withdrawn
Condition(s):Alcoholic Liver DiseaseLast Updated:March 17, 2022Recruiting
Condition(s):Pneumocystis; Pneumocystis Pneumonia; Pneumocystis Jirovecii Infection; Pneumocystis Infections; Pneumocystis Carinii Infection; Pneumocystosis; Pneumonia (Etiology); Pneumocystis Carinii; Infection, Resulting From HIV Disease; Pneumocystosis Associated With AIDSLast Updated:April 6, 2022Not yet recruiting
Condition(s):HepatotoxicityLast Updated:December 13, 2005Completed
Condition(s):Liver CirrhosisLast Updated:October 3, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.